Randomized double-blind clinical trial of a new human epoetin versus a commercially available formula for anemia control in patients on hemodialysis.

Clinics (Sao Paulo) · 2014 · PMC4129558 · PMID 25141114

Europe PMC DOI

hedged sentence

0.1120

closest p · 2.2× alpha

0.1120

boldest claim

The sentences

did not reach statistical significancep = 0.112not close (p > 0.1)

Over the final 3 months of the study, mean monthly hemoglobin levels were slightly higher in the EpoBM group, but this difference did not reach statistical significance ( p = 0.112).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.